β-Cyclodextrin-Modified Methylene Blue–Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy
ACS Applied Bio Materials · 17.11.2026
DOI: 10.1021/acsabm.6c01927 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 17.11.2026. Verfasst von Adei Abouhagger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Materials and Electronics, State Research Institute Center for Physical Sciences and Technology (FTMC), VilniusLT-02300, Lit…. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial photodynamic therapy offers a route to bacterial inactivation that does not depend on conventional resistance mechanisms, and methylene blue (MB) is among the most established photosensitizers. Its efficiency, however, is governed by aggregation state: only monomeric MB generates singlet oxygen efficiently, while the dimers that form within negatively charged carriers such as alginate are photodynamically inactive. Here, we report a droplet-microfluidic platform for fabricating monodisperse MB-loaded calcium alginate microgels and exploit β-cyclodextrin (β-CD) co-encapsulation to control the monomer fraction of the released dye. Internal-gelation flow-focusing produced uniform microgels (∼132 µm; coefficient of variation 2.1%), within which increasing β-CD content progressively raised the monomeric fraction of the released MB, as quantified by the A664/A610 absorbance ratio. Photosensitized ROS generation under 630 nm irradiation, measured with 1,3-diphenylisobenzofuran in a medium that preserves MB aggregation, was 1.9-fold higher for the β-cyclodextrin formulation, and the microgels produced clear, light-dependent killing of Staphylococcus aureus and Escherichia coli. β-Cyclodextrin co-encapsulation significantly enhanced bactericidal activity against S. aureus (p < 0.01), with the same trend in E. coli. By making photosensitizer monomer fraction, dose, and carrier geometry separately measurable and tunable within a single monodisperse platform, this work provides a route toward the rational optimization of photodynamic antibacterial microgels.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Functional Materials and Electronics, State Research Institute Center for Physical Sciences and Technology (FTMC), VilniusLT-02300, Lithuania.
ORCID-Profile: Adei Abouhagger, Laura Milaknytė, Wanessa de Melo, Arūnas Stirkė, Povilas Šimonis
Zitieren
APA
Abouhagger, A., Milaknytė, L., de Melo, W., Stirkė, A., & Šimonis, P. (2026). β-Cyclodextrin-Modified Methylene Blue–Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c01927
Vancouver
Abouhagger A, Milaknytė L, de Melo W, Stirkė A, Šimonis P. β-Cyclodextrin-Modified Methylene Blue–Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c01927
BibTeX
@article{Abouhagger2026,
author = {Abouhagger, Adei and Milaknytė, Laura and de Melo, Wanessa and Stirkė, Arūnas and Šimonis, Povilas},
title = {β-Cyclodextrin-Modified Methylene Blue–Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c01927}
}
EUVIMED